The transcriptomic activities of three HER2 effector pathways (PI3K-AKT, MAPK, and JAK-STAT) were investigated using RNA sequencing, and the mutational status of key breast cancer-associated genes was determined using DNA sequencing. Here, ERBB2 is linked to breast carcinoma.